Cat. No.: X24-09-YM332
Isocitrate dehydrogenase (IDH) inhibitor, GSK864, Purity ≥98%
Synonym: 1816331-66-4; GSK 864; GSK-864; (7S)-1-[(4-Fluorophenyl)methyl]-3-N-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,6-dihydropyrazolo[4,3-c]pyridine-3,7-dicarboxamide; Isocitrate dehydrogenase (IDH) inhibitor
- CAS Number: 1816331-66-4
- Compound CID: 91864701
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
GSK864 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting isocitrate dehydrogenase (IDH). The molecular weight of the compound is 558.6, and its molecular formula is C30H31FN6O4.
Molecular Formula
C30H31FN6O4
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK864 plays a key role in inhibiting the mutant IDH1 enzyme, which is involved in cancer progression.
Related Products
-
Isocitrate dehydrogenase (IDH) inhibitor, AGI-5198, Purity ≥98%
-
Isocitrate dehydrogenase (IDH) inhibitor, AGI-6780, Purity ≥98%
-
Isocitrate dehydrogenase (IDH) inhibitor, IDH-C227, Purity ≥98%
-
Isocitrate dehydrogenase (IDH) inhibitor, AG-120 racemic, Purity ≥98%
-
Isocitrate dehydrogenase (IDH) inhibitor, Enasidenib, Purity ≥98%
-
Isocitrate dehydrogenase (IDH) inhibitor, Vorasidenib, Purity ≥98%
Quick Links